AZD2171 cancer drug molecule

Numéro d’image : 11522390
AZD2171 cancer drug molecule
AZD2171 cancer drug. Computer model of a molecule of the cancer drug AZD2171. This drug (trade name Recentin) is being developed by AstraZeneca. As of 2007 it is undergoing clinical trials for treatment of non-small cell lung cancer and colorectal cancer in adults,as well as tumours of the central nervous system in children. It belongs to a class of drugs known as tyrosine kinase inhibitors. These drugs bind to tyrosine kinase growth factor receptors on the cancer cell's surface,inactivating them and so stopping cell growth and proliferation. Atoms are colour-coded: carbon (yellow),hydrogen (white),nitrogen (blue),fluorine (green) and oxygen (red)
Licence : Droits gérés
Crédit: Science Photo Library / Evans, Dr. Tim
Taille de l’image : 4200 px × 3150 px
Model Release : Non requis
Property Release : Non requis
Restrictions : -

Prix pour cette image À partir de 45 €

Produit vendu
(Calendrier, Carte postale, Carte de vœux, Impression sur textile, Packaging etc)
À partir de 45 €
Usage commercial
(Affichage, Annonce presse, Annonce TV, Carte, Digital - hors rés. sociaux, Digital - rés. sociaux etc)
À partir de 45 €
Éditorial
(Digital, Journal, Livre, Livre pratique, Magazine, Télévision etc)
À partir de 60 €
Usage non-commercial
(Digital - hors rés. sociaux, Digital - rés. sociaux etc)
À partir de 120 €

Mots clés

;